Style | Citing Format |
---|---|
MLA | Beigi FH, et al.. "Assessment of Ploy Dopamine Coated Fe3o4 Nanoparticles for Melanoma (B16-F10 and A-375) Cells Detection." Anti-Cancer Agents in Medicinal Chemistry, vol. 20, no. 16, 2020, pp. 1918-1926. |
APA | Beigi FH, Fatahian S, Shahbazigahrouei S, Shahbazigahrouei D, Farzadniya A (2020). Assessment of Ploy Dopamine Coated Fe3o4 Nanoparticles for Melanoma (B16-F10 and A-375) Cells Detection. Anti-Cancer Agents in Medicinal Chemistry, 20(16), 1918-1926. |
Chicago | Beigi FH, Fatahian S, Shahbazigahrouei S, Shahbazigahrouei D, Farzadniya A. "Assessment of Ploy Dopamine Coated Fe3o4 Nanoparticles for Melanoma (B16-F10 and A-375) Cells Detection." Anti-Cancer Agents in Medicinal Chemistry 20, no. 16 (2020): 1918-1926. |
Harvard | Beigi FH et al. (2020) 'Assessment of Ploy Dopamine Coated Fe3o4 Nanoparticles for Melanoma (B16-F10 and A-375) Cells Detection', Anti-Cancer Agents in Medicinal Chemistry, 20(16), pp. 1918-1926. |
Vancouver | Beigi FH, Fatahian S, Shahbazigahrouei S, Shahbazigahrouei D, Farzadniya A. Assessment of Ploy Dopamine Coated Fe3o4 Nanoparticles for Melanoma (B16-F10 and A-375) Cells Detection. Anti-Cancer Agents in Medicinal Chemistry. 2020;20(16):1918-1926. |
BibTex | @article{ author = {Beigi FH and Fatahian S and Shahbazigahrouei S and Shahbazigahrouei D and Farzadniya A}, title = {Assessment of Ploy Dopamine Coated Fe3o4 Nanoparticles for Melanoma (B16-F10 and A-375) Cells Detection}, journal = {Anti-Cancer Agents in Medicinal Chemistry}, volume = {20}, number = {16}, pages = {1918-1926}, year = {2020} } |
RIS | TY - JOUR AU - Beigi FH AU - Fatahian S AU - Shahbazigahrouei S AU - Shahbazigahrouei D AU - Farzadniya A TI - Assessment of Ploy Dopamine Coated Fe3o4 Nanoparticles for Melanoma (B16-F10 and A-375) Cells Detection JO - Anti-Cancer Agents in Medicinal Chemistry VL - 20 IS - 16 SP - 1918 EP - 1926 PY - 2020 ER - |